A variety of lncRNAs and miRNAs such as PCA3, PCAT-1, MALAT1, miR-205 and miR-34a, have been experimentally and clinically reported to be involved in PCa and serve as potential biomarkers or therapeutic targets for PCa [20]. The gene discussed is PCAT1; the disease is posterior cortical atrophy.